期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

巨噬细胞移动抑制因子在肿瘤发病机制中的研究进展 被引量：14

Macrophage migration inhibitory factor in the development and progression of tumors
暂未订购
导出
摘要 巨噬细胞移动抑制因子(macrophage migration inhibitory factor,MIF)是一种多功能细胞因子,通过各种途径参与机体各种炎症性和自身免疫性疾病及肿瘤的发生与发展。文中综述MIF在肿瘤发生发展过程中分子作用机制的研究进展。 Macrophage migration inhibitory factor （ MIF）, a muhifunctional cytokine, is involved in the development and progression of many inflammatory autoimmune diseases and tumors through various pathways. In this paper, we reviewed the latest progress in the studies of the molecular mechanisms of MIF in the development and progression of tumors.
作者 樊根涛 吴苏稼
机构地区 南京大学医学院临床学院骨科(南京军区南京总医院)
出处 《医学研究生学报》 CAS 北大核心 2013年第1期77-79,共3页 Journal of Medical Postgraduates
基金 江苏省自然科学基金(BK2010461)
关键词 巨噬细胞移动抑制因子 恶性肿瘤 分子机制 Macrophage migration inhibitory factor Malignant tumor Molecular mechanism
分类号 R730.2 [医药卫生—肿瘤]
  • 相关文献

参考文献29

  • 1Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed2type hypersensitivity[J]. Science, 1966, 153(731): 80-82.
  • 2Weiser WY, Temple PA, Witek G, et al. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor[J]. Proc Natl Acad Sci, 1989, 86(19):7522-7526.
  • 3Imamura K, Nishihira J, Suzuki M, et al. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney[J]. Biochem Mol Biol Int, 1996, 40(6):1233-1242.
  • 4Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide[J]. Cytokine, 1998, 10(3):199-205.
  • 5Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation[J]. Proc Natl Acad Sci USA, 1996, 93(15):7849-7854.
  • 6Calandra T, Bernhagen J, Mitchell RA, et al. The macrophage is an important and previously unrecognized source of acrophage migration inhibitory factor[J]. J Exp Med, 1994, 179(6):1895-1902.
  • 7郭建秀,胡川闽.巨噬细胞移动抑制因子在脓毒性休克及其治疗中的作用[J].医学研究生学报,2006,19(8):748-751. 被引量：4
  • 8Bernhagen J, Calandra T, Mitchell RA, et al. MIF is a pituitary-derived cytokine that tentiates lethal endotoxaemia[J]. Nature, 1993, 365(6448):756-759.
  • 9丁粉干,张新华,官兵,王中秋.P53蛋白过表达和P53基因突变与胶质母细胞瘤预后关系的Meta分析[J].医学研究生学报,2011,24(2):163-167. 被引量：9
  • 10Mitchell RA, Liao H, Chesney J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response[J]. Proc Natl Acad Sci USA, 2002,99(1):345-350.

二级参考文献117

  • 1Fukumura D, Xavier R, Sugiura T, et al. Tumor induction of VEGF promoter activity in stromal cells [ J ]. Cell, 1998,94 (6) : 715 -725.
  • 2Hagendoorn J, Tong R, Fukumura D, et al. Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis [ J ]. Cancer Res,2006,66 (7) : 3360-3364.
  • 3Hillen F, Griffioen AW. Tumour vascularization: sprouting angiogenesis and beyond[ J]. Cancer Metastasis Rev, 2007,26 (3- 4 ) :489-502.
  • 4Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tmnorigenesis [ J]. Cell, 1996,86 (3) :353-364.
  • 5Hillen F, Griffioen AW. Tumour vascularization: sprouting an-giogenesis and beyond [ J]. Cancer Metastasis Rev, 2007,26 (3- 4 ) :489-502.
  • 6Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor ( vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract [ J ]. Cancer Res, 1993,53(19) :4727-4735.
  • 7Senger DR, Brown LF, Claffey KP, et al. Vascular permeability factor, tumor angiogenesis and stroma generation [ J]. Invasion Metastasis, 1994,14 ( 1-6 ) : 385-394.
  • 8Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas [ J ]. Am J Pathol, 1993,143 (5) : 1255-1262.
  • 9Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies [ J ]. Cancer Res, 1999,59 ( 3 ) :728-733.
  • 10Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy[ J]. J Clin Oncol, 2002, 20(21 ) :4368-4380.

共引文献37

同被引文献181

引证文献14

二级引证文献85

医学研究生学报
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部